nach oben

Erschienen in:

01.11.2023 | Media release

Voluntary recall of certain lubricant eye drops due to potential risk of eye infections

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

A voluntary recall of certain LEADER-brand lubricant eye drops supplied by Velocity Pharma, LLC, has been announced by Cardinal Health, Inc, due to the potential risk of eye infections. …

Food and Drug Administration (FDA). Cardinal Health, Inc. Issues Voluntary Nationwide Recall of Certain LEADER Brand Eye Drops Supplied by Velocity Pharma, LLC Due to Potential Risk of Eye Infections. Internet Document : 1 Nov 2023. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/cardinal-health-inc-issues-voluntary-nationwide-recall-certain-leadertm-brand-eye-drops-supplied

Titel: Voluntary recall of certain lubricant eye drops due to potential risk of eye infections
Publikationsdatum: 01.11.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-49357-x

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Voluntary recall of certain lubricant eye drops due to potential risk of eye infections

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Multiple drugs

Antineoplastics

Dapagliflozin

Dextromethorphan/doxylamine

Carboplatin/pembrolizumab/pemetrexed

Milrinone